News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Keson-Brookes Maiken
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2022 |
4
| Keson-Brookes Maiken (CLO & Corp. Secretary) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 2,732 shares
@ $6.573, valued at
$18k
Exercised 8,075 restricted stock units
@ $0
Granted 143,750 options to buy
@ $6.75, valued at
$970.3k
Granted 34,500 restricted stock units
@ $0 |
|
| 03/15/2021 |
4
| Keson-Brookes Maiken (CLO & Corp. Secretary) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 25,000 shares
@ $20.2386, valued at
$506k
Exercised 25,000 options to buy
@ $7.7, valued at
$192.5k
|
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Keson-Brookes Maiken (CLO & Corp. Secretary) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $7.7, valued at
$1.9M
|
|
| 01/31/2017 |
4
| Keson-Brookes Maiken (General Counsel) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 43,250 options to buy
@ $5.37, valued at
$232.3k
Granted 43,250 options to buy
@ $0 |
|
|
|